Читать книгу Assisted Reproduction Techniques - Группа авторов - Страница 63

1 1 Welsh MJ, Denning GM, Ostedgaard LS, Anderson MP. Dysfunction of CFTR bearing the delta F508 mutation. J Cell Sci Suppl. 1993; 17:235–9.

2 2 van der Ven K, Messer L, van der Ven H, Jeyendran RS, Ober C. Cystic fibrosis mutation screening in healthy men with reduced sperm quality. Hum Reprod. 1996; 11: 513–7.

3 3 Anguiano A, Oates RD, Amos JA, Dean M, Gerrard B, Stewart C, Maher TA, White MB, Milunsky A. Congenital bilateral absence of the vas deferens: a primarily genital form of cystic fibrosis. JAMA. 1992; 267:1794–7.

4 4 Grangeia A, Sá R, Carvalho F, Martin J, Girodon E, Silva J, Ferráz L, Barros A, Sousa M. Molecular characterization of the cystic fibrosis transmembrane conductance regulator gene in congenital absence of the vas deferens. Genet Med. 2007; 9:163–72.

5 5 Girardet A, Viart V, Plaza S, Daina G, De Rycke M, Des Georges M, et al. The improvement of the Best Practice Guidelines for Preimplantation Genetic Diagnosis of cystic fibrosis: towards an international consensus. Eur J Hum Genet. 2016; 24(4): 469–78.

6 6 Davis L, Champion S, Fair S, Baker V, Garber A. A cost‐benefit analysis of preimplantation genetic diagnosis for carrier couples of cystic fibrosis. Fertil Steril. 2010; 93:1793–1804.

7 7 Chamayou S, Sicali M, Lombardo D, Alecci C, Ragolia C, Maglia E, et al. Universal strategy for preimplantation testing for cystic fibrosis based on next generation sequencing. J Assist Reprod Genet. 2019; 37(1):213–212. DOI: 10.1007/s10815‐019‐01635‐2.

8 8 Guggino WB, Cebotaru L. Adeno‐associated Virus (AAV) genetherapy for cystic fibrosis: current barriers and recent developments. Expert Opin Bio Ther. 2017; 17:1265–73.